Condition: Ischemia Reperfusion Injury · Myocardial Injury · Acute Kidney Injury · Sponsor: Kaiser Permanente
A Randomized, Double-blind, placebo-controlled Trial to Evaluate the Efficacy of Oral Nam for the Prevention of Acute Kidney Injury in Patients Undergoing On-Pump Cardiac Surgery
This description comes directly from the study's public registry record.
Ali Poyan Mehr, MD · 4152644750 · ali.x.poyanmehr@kp.org
Always discuss trial participation with your own doctor first.
| Kaiser Permanente San Francisco Medical Center | San Francisco, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04750616